Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
Cows with severe mastitis treated with pegbovigrastim, along with standard antibiotics and anti-inflammatory drugs, were more likely to survive the first 30 days after treatment than those given a placebo. However, the treatment did not improve milk production or bacterial cure rates.
Nov 1, 2021